05.06.
2024
“Building the bridge from preclinical to clinical studies” – a panel discussion
We are pleased to invite to a further "Talk in the Cube” on Thursday, June 13, 2024, from 5:00 - 6:30 p.m. at BerlinBioCube (Building 95), Campus Berlin-Buch
The transition from preclinical studies to human clinical trials is challenging in many ways - scientifically, regulatory and organizationally and companies need to become even more efficient to get their drugs through the development process, e.g.
• Reflect clinical problems in preclinical models,
• Balance in vitro, animal and human experimentation from an ethical point of view,
• Comply with regulatory requirements such as ICH, EMA, FDA etc.,
• Remain financially successful.
with
Jens Hoffmann, Managing Director of Experimental Pharmacology & Oncology (EPO), Berlin-Buch GmbH,
Michael Firgens, Managing Director at MF Biotech, Berlin,
Rocio Mugica Nava, Director, Regulatory Affairs, Worldwide Clinical Trials, Madrid, Spain,
Uwe Lohmeier, Head of Gläsernes Labor Akademie (GLA), Campus Berlin-Buch GmbH (Moderation)
Don't miss the opportunity to join in the discussion and exchange ideas with each other and our experts over snacks and drinks at the subsequent get-together and networking event.
Registration and further information at https://www.glaesernes-labor-akademie.de/de/talk-im-cube
M. Wuestenhagen, Berlin Partner